| Zacks Company Profile for PetMed Express, Inc. (PETS : NSDQ) |
|
|
| |
| • Company Description |
| PetMed Express, Inc. and subsidiaries, d/b/a 1-800-PetMeds (the `Company`), is a leading nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The Company offers consumers an attractive alternative for obtaining pet medications in terms of convenience, price, and speed of delivery. The Company markets its products through national advertising campaigns, which aim to increase the recognition of the `1-800-PetMeds` brand name, and `PetMeds` family of trademarks, increase traffic on its website at www.1800petmeds.com, acquire new customers, and maximize repeat purchases. The majority of the Company's sales are to residents in the United States. The Company's corporate headquarters and distribution facility are located in Delray Beach, Florida.
Number of Employees: 173 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $2.45 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 114,830 shares |
| Shares Outstanding: 21.02 (millions) |
| Market Capitalization: $51.49 (millions) |
| Beta: 0.73 |
| 52 Week High: $6.85 |
| 52 Week Low: $2.42 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-3.54% |
-3.33% |
| 12 Week |
-20.97% |
-23.93% |
| Year To Date |
-49.17% |
-55.51% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Leslie C.G. Campbell - Interim Chief Executive Officer;President ;Executi
Doug Krulik - Chief Accounting Officer; Interim Principal Financ
Gian M. Fulgoni - Director
Justin Mennen - Director
Leah Solivan - Director
|
|
Peer Information
PetMed Express, Inc. (COOL.)
PetMed Express, Inc. (GFME)
PetMed Express, Inc. (GSVI)
PetMed Express, Inc. (GDENZ)
PetMed Express, Inc. (EMUS)
PetMed Express, Inc. (BFLY.)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: INTERNET COMMERCE
Sector: Retail/Wholesale
CUSIP: 716382106
SIC: 5912
|
|
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 11/05/25
|
|
Share - Related Items
Shares Outstanding: 21.02
Most Recent Split Date: (:1)
Beta: 0.73
Market Capitalization: $51.49 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $-0.06 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $-0.22 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 1.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 11/05/25 |
|
|
|
| |
